Hemab Therapeutics Holdings, Inc. Common Stock
$44.84
-4.65 (-9.40%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -5.5%
- 3 Months
- +57.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since May 2026
- -26.5%
Own COAG?
See how COAG contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.